- Home
- / AlzeCure Pharma
AlzeCure Pharma
Stock Price
KR1.8
2024-10-29
Market Capitalization
KR158.9 M
2024-10-29
AlzeCure Pharma Summary
Company Summary
- Overview
- AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders. It provides a NeuroRestore platform that consists of symptom-relieving drug candidates and Alzstatin platform that includes disease-modifying and preventative drug candidates.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- Huddinge, SE | view all locations
- Cybersecurity rating
Table of Contents
Key People
Thomas Pollare, Chairman and Member of the Board
Johan Sandin, CSO
Ellen Donnelly, Director
LocationsView all
1 location detected
Huddinge, Stockholms län HQ
Sweden
Hälsovägen 7
AlzeCure Pharma Financials
Summary Financials
- Gross profit (Q1, 2026)
- kr2.3M
- Net income (Q1, 2026)
- (kr21.7M)
- Cash (Q1, 2026)
- kr33.0M
- EBIT (Q1, 2026)
- (kr21.8M)
- Enterprise value
- $128.3M